Tackling Racial Inequalities in HBV Care Globally

In this episode, Geoffrey Dusheiko, FRCP, FRCP (Edin), FCP (SA), and Ming-Lung Yu, MD, PhD, discuss key racial inequities of care that lead to undertreatment for migrant populations and other racial minorities globally with or at risk for hepatitis B. In addition, they discuss plans to improve engagement across the care continuum and strategies to combat implicit racial biases that affect optimal HBV care.

Topics include:

• Differences in the burden of HBV globally
• Suboptimal engagement of HBV care
• Stigma associated with HBV care
• Key strategies for overcoming racial barriers
• First-hand patient stories

Geoffrey Dusheiko, FRCP, FRCP (Edin), FCP (SA)
Emeritus Professor of Medicine
Consultant Hepatologist
University College London Medical School
Professor
Liver Unit
Kings College Hospital
London, United Kingdom

Ming-Lung Yu, MD, PhD
Chair Professor
Hepatobiliary Division
Department of Internal Medicine and Hepatitis Center
Kaohsiung Medical University
Visiting Staff
Hepatobiliary Division
Department of Internal Medicine
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
Kaohsiung City, Taiwan 

Content based on a CME program supported by educational grants provided by AbbVie; Gilead Sciences, Inc.; and Janssen Therapeutics, Division of Janssen Products, LP 

To follow along, download the slides at:
https://bit.ly/3gWStjZ

Link to full program: 
https://bit.ly/3kKIb9a